Kristen Bosse, Director of Product Development, is CRIO’s in-house product guru. In this Ask Me Anything, a CRIO expert roundup, Kristen discusses CRIO’s products, UX design and beta testing, and shares recommendations for sponsors looking to identify the best sites for their trials. What differentiates CRIO’s products from any other products on the market? We...
eConsent: The Benefits With the recent push toward Decentralized Clinical Trials, many sponsors are adopting eConsent. eConsent allows patients to consent electronically, whether in clinic or remotely, from the convenience of their home. eConsent offers sponsors, CROs investigators and patients these benefits: Removal of errors by ensuring completion of all fields Accuracy of date-times through...
Jonathan Andrus, President & COO at CRIO, is an active thought-leader and presenter in the life sciences industry. He serves on the board and executive committee of the Society for Clinical Data Management (SCDM) and is co-lead with the Decentralized Trials and Research Alliance (DTRA) workstream initiative. The year was 1996 – the year that...
Entry of pharmacy chains into clinical research CVS Health CVS Health was the first of the major pharmacy chains to publicly enter the clinical research space when they launched CVS Health Clinical Trial Services in May 2021. They launched this new business arm initially to facilitate clinical trials for COVID-19 vaccines and treatments. While the...
Networks are brick and mortar businesses by definition, but their differentiation lies in their ability to incorporate and optimize technology in every step of the workflow. No single technology vendor will be able to service the full gamut of needs. Instead, leadership teams should select and configure optimal solutions for different stages of the value...
There are plenty of instances where institutional capital goes into a sector, only to fizzle out. Why are we confident that the site network trend is real, and not hype? We’ve identified 4 main levers of revenue and profit growth for network consolidation. In order, from the “quick hit” to the heaviest lift: Business Development...
Valuation of site for purchase by site networks As site networks compete with each other to purchase clinical research sites, certain valuation standards have emerged. For sites that achieve a scale threshold, an exit is possible at a multiple of the site’s EBITDA. EBITDA stands for earnings before taxes, interest, depreciation and amortization, and it’s...
In a 2019 CRIO eBook, “Scaling and Innovating: The Consolidation and Reinvention of Clinical Research Sites” we explored the emerging trend of clinical research site consolidation. Our predictions were prescient. Today, the number of institutional investors in the space has increased more than 7-fold since 2015, with no sign of abating. We at CRIO predict...
With the recent push toward Decentralized Clinical Trials (DCTs), many sponsors are adopting eConsent. eConsent allows patients to consent electronically, whether in clinic or remotely, from the convenience of their home. eConsent offers sponsors, CROs, investigators and patients these benefits: Reduce errors by ensuring completion of all fields Automated audit trails ensure accuracy of date-times...
Reflections on the Summit The 2021 Global Site Solutions Summit, hosted by the Society for Clinical Research Sites, was an amazing event. The first in-person event that our company has attended in 18 months, the Summit provided an opportunity for CRIO to meet new people and reconnect with clients and friends alike. Post-Pandemic Trends, Here...
What’s wrong with the way that most sites have been recording data for decades? While much of research data is still being collected on paper, digital adoption across source, regulatory and remote monitoring is rapidly increasing among sponsors, CROs, and research sites. Many of the challenges that Principal Investigators (PIs) face during the conduct of...
Clinical Research IO (CRIO)’s recent site survey showed that most sites have recovered business lost during the pandemic, are adjusting to the decentralized clinical trial model, and have implemented their own software in response. At the beginning of the pandemic, CRIO conducted a survey to look at the impact of coronavirus on research sites. By...